Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells

The deregulation of lipid metabolism is a hallmark of tumor cells, and elevated lipogenesis has been reported in prostate cancer. Metformin, a drug commonly prescribed for type II diabetes, displays antitumor properties. Here, we show that metformin inhibits lipogenesis in several prostate cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Loubière, Camille, Goiran, Thomas, Laurent, Kathiane, Djabari, Zied, Tanti, Jean-François, Bost, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558177/
https://www.ncbi.nlm.nih.gov/pubmed/26002551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558177/
https://www.ncbi.nlm.nih.gov/pubmed/26002551

Ejemplares similares